Drug Pricing Reform Unlikely to Affect Smaller Biotech Companies
June 24, 2021 at 06:00 AM EDT
Investing in healthcare stocks is compelling for many investors because of the defensive qualities of blue chip pharmaceuticals companies and the growth prospects of biotechnology names. However, as sustainable investing becomes an increasingly prominent part of the investment lexicon, some may...